Novel approaches to the development of anti-sepsis drugs

Bibliography

• Maloney PJ. Sepsis and septic shock. Emerg Med Clin North Am 2013;31:583-600
   PubMed Web of Science ®Google Scholar
• Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007;35:1244-50
   PubMed Web of Science ®Google Scholar
• Randolph AG, McCulloh RJ. Pediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents. Virulence 2014;5:179-89
   PubMed Web of Science ®Google Scholar
• Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis. Pediatr Crit Care Med 2013;14:686-93
   PubMed Web of Science ®Google Scholar
• Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840-51
   PubMed Web of Science ®Google Scholar
• Gentile L, Cuenza A, Efron P, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 2012;72:1491-501
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013;13:260-8
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Opal S. Immunotherapy for sepsis – a new approach against an ancient foe. N Engl J Med 2010;363:87-9
   PubMed Web of Science ®Google Scholar
• Boomer JS, Green JM, Hotchkiss RS. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence 2013;5:45-56
   PubMedGoogle Scholar
• Tarnow-Mordi W, Isaacs D, Dutta S. Adjunctive immunologic interventions in neonatal sepsis. Clin Perinatol 2010;37:481-99
   PubMed Web of Science ®Google Scholar
• Ward PA. New approaches to the study of sepsis. EMBO Mol Med 2012;4:1234-43
   Google Scholar
• Venet F, Lukaszewicz A, Payen D, et al. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol 2013;25:477-83
   PubMed Web of Science ®Google Scholar
• Barati M, Alinejad F, Bahar MA, et al. Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases. Burns 2008;34:770-4
   PubMed Web of Science ®Google Scholar
• Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, et al. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med 2009;35:1950-8
   PubMed Web of Science ®Google Scholar
• Bhandari V, Wang C, Rinder C, Rinder H. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics 2008;121:129-34
   PubMed Web of Science ®Google Scholar
• Icardi M, Erickson Y, Kilborn S, et al. CD64 index provides simple and predictive testing for detection and monitoring of sepsis and bacterial infection in hospital patients. J Clin Microbiol 2009;47:3914-19
   PubMed Web of Science ®Google Scholar
• Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206-17
   PubMed Web of Science ®Google Scholar
• Dimoula A, Pradier O, Kassengera Z, et al. Serial determinations of neutrophil CD64 expression for the diagnosis and monitoring of sepsis in critically ill patients. Clin Infect Dis 2014;58:820-9
   PubMed Web of Science ®Google Scholar
• Monneret G, Venet F, Meisel C, Schefold J. Assessment of monocytic HLA-DR expression in ICU patients: analytical issues for multicentric flow cytometry studies. Crit Care 2010;14:432
   PubMedGoogle Scholar
• Russell JA, Boyd J, Nakada T, et al. Molecular mechanisms of sepsis. Contrib Microbiol 2011;17:48-85
   PubMedGoogle Scholar
• Schatz AR, Lee M, Condie RB, et al. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 1997;142:278-87
   PubMed Web of Science ®Google Scholar
• Klein TW, Cabral GA. Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. J Neuroimmune Pharmacol 2006;1:50-64
   PubMed Web of Science ®Google Scholar
• Kreth S, Kaufmann I, Ledderose C, et al. Reduced ligand affinity leads to an impaired function of the adenosine A2A receptor of human granulocytes in sepsis. J Cell Mol Med 2009;13:985-94
   PubMed Web of Science ®Google Scholar
• Tschöp J, Kasten KR, Nogueiras R, et al. The cannabinoid receptor 2 is critical for the host response to sepsis. J Immunol 2009;183:499-505
   PubMed Web of Science ®Google Scholar
• Hoesel L, Neff T, Neff S, Younger J. Harmful and protective roles of neutrophils in sepsis. Shock 2005;24:40-7
   PubMed Web of Science ®Google Scholar
• Varga K, Wagner JA, Bridgen DT, Kunos G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. Faseb J 1998;12:1035-44
   PubMed Web of Science ®Google Scholar
• Schwarz H, Blanco FJ, Lotz M. Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol 1994;55:107-15
   PubMed Web of Science ®Google Scholar
• Oka S, Wakui J, Ikeda S, et al. Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. J Immunol 2006;177:8796-805
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Del Giudice E, Furegato S, et al. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia 2003;41:161-8
   PubMed Web of Science ®Google Scholar
• Gallily R, Breuer A, Mechoulam R. 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. Eur J Pharmacol 2000;406:R5-7
   PubMed Web of Science ®Google Scholar
• Kianian M, Al-Banna N, Kelly M, Lehmann C. Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut. J Basic Clin Physiol Pharmacol 2013;24:27-33
   PubMedGoogle Scholar
• Underhill DM. Toll-like receptors: networking for success. Eur J Immunol 2003;33:1767-75
   PubMed Web of Science ®Google Scholar
• Opal SM, Laterre P-F, Francois B, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 2013;309:1154-62
   PubMed Web of Science ®Google Scholar
• Kemna E, Pickkers P, Nemeth E, et al. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106:1864-6
   PubMed Web of Science ®Google Scholar
• Kollmann TR, Crabtree J, Rein-Weston A, et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009;183:7150-60
   PubMed Web of Science ®Google Scholar
• Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54
   PubMed Web of Science ®Google Scholar
• Thompson CM, Holden TD, Rona G, et al. Toll-like receptor 1 polymorphisms and associated outcomes in sepsis after traumatic injury: a candidate gene association study. Ann Surg 2013;259:179-85
   Web of Science ®Google Scholar
• Thair SA, Russell JA. Sepsis in transit: from clinical to molecular classification. Crit Care 2012;16:173
   PubMedGoogle Scholar
• Armstrong L, Medford ARL, Hunter KJ, et al. Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 2004;136:312-19
   PubMedGoogle Scholar
• Duits LA, Ravensbergen B, Rademaker M, et al. Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 2002;106:517-25
   PubMed Web of Science ®Google Scholar
• Spittler A, Razenberger M, Kupper H, et al. Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production. Clin Infect Dis 2000;31:1338-42
   PubMed Web of Science ®Google Scholar
• Abe R, Hirasawa H, Oda S, et al. Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. J Surg Res 2008;147:1-8
   PubMed Web of Science ®Google Scholar
• Byrne A, Reen DJ. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J Immunol 2002;168:1968-77
   PubMed Web of Science ®Google Scholar
• Corbett NP, Blimkie D, Ho KC, et al. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS One 2010;5:e15041
   PubMed Web of Science ®Google Scholar
• Clark SR, Ma AC, Tavener SA, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007;13:463-9
   PubMed Web of Science ®Google Scholar
• Tillack K, Breiden P, Martin R, Sospedra M. T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. J Immunol 2012;188:3150-9
   PubMed Web of Science ®Google Scholar
• Faller S, Strosing KM, Ryter SW, et al. The volatile anesthetic isoflurane prevents ventilator-induced lung injury via phosphoinositide 3-kinase/Akt signaling in mice. Anesth Analg 2012;114:747-56
   PubMed Web of Science ®Google Scholar
• Tarnow-Mordi W, Kumar P, Kler N. Neonatal trials need thousands, not hundreds, to change global practice. Acta Paediatr 2011;100:330-3
   PubMed Web of Science ®Google Scholar
• Moon H, Kang C, Choi J, et al. Acetyl salicylic acid inhibits Th17 airway inflammation via blockade of IL-6 and IL-17 positive feedback. Exp Mol Med 2013;45:e5
   Google Scholar
• Li J, Zhang Y, Lou J, et al. Neutralisation of peritoneal IL-17A markedly improves the prognosis of severe septic mice by decreasing neutrophil infiltration and proinflammatory cytokines. PLoS One 2012;7:e46506
   PubMedGoogle Scholar
• O´Neal H, Koyoma T, Koehler E, et al. Prehospital statin and aspirin use and the prevalence of severe sepsis and ALI/ARDS. Crit Care Med 2011;39:1343-50
   PubMed Web of Science ®Google Scholar
• Nahid MA, Satoh M, Chan EK. MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 2011;8:388-403
   PubMed Web of Science ®Google Scholar
• Hou J, Wang P, Lin L, et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009;183:2150-8
   PubMed Web of Science ®Google Scholar
• Rossato M, Curtale G, Tamassia N, et al. IL-10-induced microRNA-187 negatively regulates TNF-alpha, IL-6, and IL-12p40 production in TLR4-stimulated monocytes. Proc Natl Acad Sci USA 2012;109:E3101-10
   PubMed Web of Science ®Google Scholar
• Curtale G, Mirolo M, Renzi TA, et al. Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci USA 2013;110:11499-504
   PubMed Web of Science ®Google Scholar
• Lee JC, Espéli M, Anderson CA, et al. Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway. Cell 2013;155:57-69
   PubMedGoogle Scholar
• Nahid MA, Yao B, Dominguez-Gutierrez PR, et al. Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by miR-132 and miR-212. J Immunol 2013;190:1250-63
   PubMed Web of Science ®Google Scholar
• Banin E, Vasil ML, Greenberg EP. Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci USA 2005;102:11076-81
   PubMed Web of Science ®Google Scholar
• Moreau-Marquis S, O'Toole GA, Stanton BA. Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am J Respir Cell Mol Biol 2009;41:305-13
   PubMed Web of Science ®Google Scholar
• Sow F, Florence W, Satoskar A, et al. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J Leukoc Biol 2007;82:934-45
   PubMed Web of Science ®Google Scholar
• Fratti RA, Belanger PH, Ghannoum MA, et al. Endothelial cell injury caused by Candida albicans is dependent on iron. Infect Immun 1998;66:191-6
   PubMed Web of Science ®Google Scholar
• Trzeciak S, Rivers EP. Clinical manifestations of disordered microcirculatory perfusion in severe sepsis. Crit Care 2005;9(Suppl 4):S20-6
   PubMedGoogle Scholar
• Donati A, Domizi R, Damiani E, et al. From macrohemodynamic to the microcirculation. Crit Care Res Pract 2013;2013:892710
   PubMedGoogle Scholar
• Rady MY, Rivers EP, Nowak RM. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med 1996;14:218-25
   PubMed Web of Science ®Google Scholar
• Condon MR, Kim JE, Deitch EA, et al. Appearance of an erythrocyte population with decreased deformability and hemoglobin content following sepsis. Am J Physiol Heart Circ Physiol 2003;284:H2177-84
   PubMed Web of Science ®Google Scholar
• De Backer D, Donadello K, Taccone FS, et al. Microcirculatory alterations: potential mechanisms and implications for therapy. Ann Intensive Care 2011;1:27
   PubMed Web of Science ®Google Scholar
• Price SA, Spain DA, Wilson MA, et al. Subacute sepsis impairs vascular smooth muscle contractile machinery and alters vasoconstrictor and dilator mechanisms. J Surg Res 1999;83:75-80
   PubMed Web of Science ®Google Scholar
• Trzeciak S, Cinel I, Dellinger RP, et al. Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008;15:399-413
   PubMed Web of Science ®Google Scholar
• Harrois A, Dupic L, Duranteau J. Targeting the microcirculation in resuscitation of acutely unwell patients. Curr Opin Crit Care 2011;17:303-7
   PubMed Web of Science ®Google Scholar
• López A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004;32:21-30
   PubMed Web of Science ®Google Scholar
• Trzeciak S, Dellinger RP, Parrillo JE, et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007;49:88-98
   PubMed Web of Science ®Google Scholar
• Payen D, Luengo C, Heyer L, et al. Is thenar tissue hemoglobin oxygen saturation in septic shock related to macrohemodynamic variables and outcome? Crit Care 2009;13(Suppl 5):S6
   PubMed Web of Science ®Google Scholar
• Pottecher J, Deruddre S, Teboul J-L, et al. Both passive leg raising and intravascular volume expansion improve sublingual microcirculatory perfusion in severe sepsis and septic shock patients. Intensive Care Med 2010;36:1867-74
   PubMed Web of Science ®Google Scholar
• Träger K, DeBacker D, Radermacher P. Metabolic alterations in sepsis and vasoactive drug-related metabolic effects. Curr Opin Crit Care 2003;9:271-8
   PubMedGoogle Scholar
• Gutierrez G, Williams JD. The riddle of hyperlactatemia. Crit Care 2009;13:176
   PubMedGoogle Scholar
• Kang YR, Um SW, Koh WJ, et al. Initial lactate level and mortality in septic shock patients with hepatic dysfunction. Anaesth Intensive Care 2011;39:862-7
   PubMed Web of Science ®Google Scholar
• Lima A, van Bommel J, Sikorska K, et al. The relation of near-infrared spectroscopy with changes in peripheral circulation in critically ill patients. Crit Care Med 2011;39:1649-54
   PubMed Web of Science ®Google Scholar
• Boerma EC, Kuiper MA, Kingma WP, et al. Disparity between skin perfusion and sublingual microcirculatory alterations in severe sepsis and septic shock: a prospective observational study. Intensive Care Med 2008;34:1294-8
   PubMed Web of Science ®Google Scholar
• Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010;303:739-46
   PubMed Web of Science ®Google Scholar
• Vallée F, Vallet B, Mathe O, et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock? Intensive Care Med 2008;34:2218-25
   PubMed Web of Science ®Google Scholar
• Hernandez G, Bruhn A, Castro R, Regueira T. The holistic view on perfusion monitoring in septic shock. Curr Opin Crit Care 2012;18:280-6
   PubMed Web of Science ®Google Scholar
• Vincent JL, Zhang H, Szabo C, Preiser JC. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000;161:1781-5
   PubMed Web of Science ®Google Scholar
• Channon KM. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med 2004;14:323-7
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Hirata K. Endothelial nitric oxide synthase uncoupling: is it a physiological mechanism of endothelium-dependent relaxation in cerebral artery? Cardiovasc Res 2007;73:8-9
   PubMed Web of Science ®Google Scholar
• Szabó C, Módis K. Pathophysiological roles of peroxynitrite in circulatory shock. Shock 2010;34(Suppl 1):4-14
   PubMedGoogle Scholar
• Tatham AL, Crabtree MJ, Warrick N, et al. GTP cyclohydrolase I expression, protein, and activity determine intracellular tetrahydrobiopterin levels, independent of GTP cyclohydrolase feedback regulatory protein expression. J Biol Chem 2009;284:13660-8
   PubMed Web of Science ®Google Scholar
• Hyndman ME, Verma S, Rosenfeld RJ, et al. Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 2002;282:H2167-72
   PubMed Web of Science ®Google Scholar
• Wilson JX, Wu F. Vitamin C in sepsis. Subcell Biochem 2012;56:67-83
   PubMedGoogle Scholar